We read with interest the article by Mruk and colleagues 1 demonstrating the antithrombotic and antispastic effects of flavone-8-acetic acid (flavonoid) in an animal model of a deep arterial injury. The authors conclude that "Flavonoid markedly reduced platelet deposition, mural thrombi, and injury-induced vasoconstriction after deep arterial injury, suggesting that a major inhibition of platelet glycoprotein Ib␣ may be beneficial therapy."
To the Editor:
We read with interest the article by Mruk and colleagues 1 demonstrating the antithrombotic and antispastic effects of flavone-8-acetic acid (flavonoid) in an animal model of a deep arterial injury. The authors conclude that "Flavonoid markedly reduced platelet deposition, mural thrombi, and injury-induced vasoconstriction after deep arterial injury, suggesting that a major inhibition of platelet glycoprotein Ib␣ may be beneficial therapy."
In our opinion, a major issue must be addressed regarding their conclusion. They speculated that flavonoid inhibited platelet thrombus formation by inhibiting von Willebrand factor (vWF) interaction with glycoprotein (GP) Ib␣ only on the basis of a citation of data from a previous publication indicating that flavonoid has an inhibitory effect on ristocetin-induced platelet aggregation. 2 Although it is true that recent investigations have shown a crucial role of vWF interaction with GP Ib␣ in platelet thrombus formation at sites exposed to high shear stress, 3 the unique characteristics of the vWF-GP Ib␣ interaction that occurs under high shear stress cannot be mimicked by the interaction induced by exogenous modulators such as ristocetin or botrocetin. 4 The most important characteristic of vWF for platelet thrombus formation is platelet tethering by strong and transient interaction with GP Ib␣. 3,5 Stable binding of vWF on the platelet surface, which can be induced by the exogenous modulators ristocetin and botrocetin and is mediated exclusively by its binding to GP Ib␣, never occurs under flow conditions in the absence of these modulators. 4 The stable attachment of vWF on the platelet surface can only be observed when vWF is concurrently bound with both GP Ib␣ and GP IIb/IIIa. 3, 4 Thus, the fact that flavonoid inhibits ristocetin-induced platelet aggregation does not provide any direct evidence that it inhibits arterial thrombus formation through an inhibition of vWF-GP Ib␣ interaction. Therefore, although the conclusion that "Flavonoid markedly reduced platelet deposition and mural thrombi after deep arterial injury" may still be acceptable, we do not think the role of GP 
